Electromed, Inc. (ELMD) |
|
12.45 -0.05 (-0.4%)
|
05-16 02:28 |
|
Open: |
12.51 |
Pre. Close: |
12.5 |
|
High:
|
12.51 |
Low:
|
12.2109 |
|
Volume:
|
10,531 |
Market Cap:
|
106(M) |
|
|
|
|
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
12.53 - 12.6 |
12.6 - 12.66 |
|
Low:
|
12.02 - 12.12 |
12.12 - 12.19 |
|
Close:
|
12.32 - 12.46 |
12.46 - 12.57 |
|
Technical analysis |
as of: 2022-05-13 4:37:48 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 14.83 One year: 15.18 |
| Support: |
Support1: 12.21 Support2: 10.15 |
| Resistance: |
Resistance1: 12.69 Resistance2: 13 |
| Pivot: |
12.52 |
| Moving Average: |
MA(5): 12.49 MA(20): 12.55
MA(100): 12.55 MA(250): 11.96  |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 38.7 %D(3): 32.3 |
| RSI: |
RSI(14): 45.8 |
| 52-week: |
High: 13.85 Low: 9.21 |
| Average Vol(K): |
3-Month: 8 (K) 10-Days: 16 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ ELMD ] has closed above bottom band by 18.3%. Bollinger Bands are 71% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Mon, 16 May 2022
Analyzing Viveve Medical (NASDAQ:VIVE) and Electromed (NYSE:ELMD) - Defense World
Sun, 15 May 2022
Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q3 2022 Results - Earnings Call Transcript - Seeking Alpha
Tue, 10 May 2022
Electromed, Inc. Announces Third Quarter Financial Results | News | bakersfield.com - The Bakersfield Californian
Sat, 07 May 2022
Critical Contrast: Masimo (NASDAQ:MASI) & Electromed (NYSE:ELMD) - Defense World
Mon, 02 May 2022
Comparing Electromed (NYSE:ELMD) & Helius Medical Technologies (NASDAQ:HSDT) - Defense World
Wed, 27 Apr 2022
Electromed (NYSE:ELMD) Now Covered by StockNews.com - Defense World
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
9 (M) |
| Shares Float |
7 (M) |
|
% Held by Insiders
|
16.7 (%) |
|
% Held by Institutions
|
45.8 (%) |
|
Shares Short
|
50 (K) |
|
Shares Short P.Month
|
60 (K) |
Stock Financials |
|
EPS
|
0.25 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0.18 |
|
EPS Est Next Year
|
0.23 |
|
Book Value (p.s.)
|
3.85 |
|
Profit Margin (%)
|
6 |
|
Operating Margin (%)
|
7.9 |
|
Return on Assets (ttm)
|
5.2 |
|
Return on Equity (ttm)
|
7 |
|
Qtrly Rev. Growth
|
24.8 |
|
Gross Profit (p.s.)
|
3.18 |
|
Sales Per Share
|
4.4 |
|
EBITDA (p.s.)
|
0.42 |
|
Qtrly Earnings Growth
|
-16.8 |
|
Operating Cash Flow
|
2 (M) |
|
Levered Free Cash Flow
|
1 (M) |
Stock Valuations |
|
PE Ratio
|
47.88 |
|
PEG Ratio
|
2.7 |
|
Price to Book value
|
3.22 |
|
Price to Sales
|
2.82 |
|
Price to Cash Flow
|
63.5 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
